UK Police Chiefs Propose Blocking Unsafe Social Media for Under16s Raising Regulatory Risks for Tech Firms Goldman Sachs CD Offering at 4 Outpaces Average Bank Rates Italy Stocks End Lower as Investingcom Italy 40 Declines 076 PepsiCo Reportedly Preparing Snack Price Hikes for Late June Borosil Glass Works Shares Triple Over Past Year on Strong Revenue and EBITDA Growth CNBC Team Trims Stock After 46 Weekly Surge Citing Parabolic Move ProfitTaking Strategy The9 Limited NCTY Q1 2012 Earnings NarrowerThanExpected Loss Signals Cost Discipline Amid Revenue Uncertainty BHFAL Q1 2026 Earnings Earnings Miss Estimates Amid Market Challenges ELBM Q4 2025 Earnings Significant EPS Miss as PreRevenue Company Navigates Development Phase WEN Q1 2026 Earnings EPS Surpasses Estimates by 241 as Value Initiatives Drive Profitability Lunai Bioworks Inc LNAI Q1 2026 Earnings PreRevenue Biotech Reports WiderThanExpected Loss Amid Pipeline Progress Caleres Q1 2026 Earnings EPS Surprises to the Upside Despite Loss Shares Rally CDT Equity Inc Warrant CDTTW Holds at 001 A Penny Stock at a Trading Crossroads STAAR Surgical Stock Edges Lower Amid Consolidation Near Key Support Levels Cathay General Bancorp CATY Posts Modest Gain Holds Above Key Support Nathans Famous NATH Holds Near 101 as RangeBound Trading Persists Hanover Insurance Group THG Retreats 2 as Insurance Sector Faces Renewed Pressure Surprising Shift in Alphabets Portfolio CME Group Ousts AST SpaceMobile as Top Holding SBI Strike Alert State Bank of India Branches May Face Disruption on May 2526 China Emerges as Leading Competitor in Humanoid Robot Workforce Integration Says Tesla CEO America Movil Targets Steady Growth Maintains 7 Billion Capex Plan China Boosts Coal Reserves to 30Day Supply as El Nino Threat Looms Markets Brace for Trio of Economic Releases GDP Revision PCE Inflation and Oil Inventories on May 28 SpaceX IPO Speculation Nvidia Earnings Bezos AI Bubble Comments Lead Morning Market Briefing Expion360 Q2 2025 Earnings EPS Beats Estimates by 307 Amid Cost Discipline Revelation Biosciences REVB Consolidates Near Key Support at 103